Globe Life Inc (GL)

Currency in USD
183.90
-0.19(-0.10%)
Closed·
183.900.00(0.00%)
·
GL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
181.00184.36
52 wk Range
127.85191.55
Key Statistics
Prev. Close
184.09
Open
181
Day's Range
181-184.36
52 wk Range
127.85-191.55
Volume
435.25K
Average Volume (3m)
648.59K
1-Year Change
31.9793%
Book Value / Share
78.36
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
193.91
Upside
+5.44%
Members' Sentiments
Bearish
Bullish
ProTips
7 analysts have revised their earnings upwards for the upcoming period

Globe Life Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

8 Buy
3 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 193.91
(+5.44% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Wells Fargo
Buy190.00+3.32%193.00MaintainJul 24, 2026
Keefe, Bruyette & Woods
Buy190.00+3.32%192.00MaintainJul 24, 2026
JPMorgan
Buy201.00+9.30%181.00MaintainJul 21, 2026
Piper Sandler
Buy200.00+8.75%-MaintainJul 20, 2026
Piper Sandler
Buy200.00+8.75%175.00MaintainJul 15, 2026

Globe Life Inc SWOT Analysis


Resilient Growth
Globe Life demonstrates robust financial health with a 6.72% revenue growth and strong EPS performance, outpacing analyst expectations in a competitive insurance landscape
Strategic Expansion
Explore Globe Life's agent force growth strategy, driving organic expansion and solidifying its market position in life and health insurance segments
Margin Dynamics
Delve into Globe Life's contrasting margin performance: strong life insurance margins offset by challenges in the health insurance segment, with expectations for future improvement
Capital Initiatives
Analysts project an average price target of $119, while Globe Life plans to unlock $1.3 billion in capital by 2025, potentially boosting shareholder returns and operational efficiency
Read full SWOT analysis

Globe Life Inc Earnings Call Summary for Q2/2026

  • Globe Life Q2 2026 EPS of $3.61 missed consensus of $3.67 by 1.6%; revenue beat at $1.6B. Shares fell 7.7% to $169.86 in after-hours trading.
  • Net operating income rose 10% YoY with life premiums up 3% to $861M, but health underwriting margin compressed to 23% from 26% prior year.
  • Company maintained FY 2026 EPS guidance of $15.55-$15.95, raised share repurchase target by $100M to $670M-$700M citing undervalued stock.
  • Direct-to-consumer unit faces transition as AI-assisted search raises advertising costs; American Income agent count fell 7% YoY, pressuring sales growth.
  • Bermuda reinsurance transaction expected Q3 2026, but meaningful capital benefits delayed until 2027 and beyond per management guidance.
Last Updated: 2026-07-23, 12:34 p/m
Read Full Transcript

Earnings

Latest Release
Jul 22, 2026
EPS / Forecast
3.61 / 3.67
Revenue / Forecast
1.6B / 1.59B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 15.08%
Dividend Yield
0.72%
Industry Median 3.25%
Annualized payout
1.32
Paid quarterly
5-Years Growth
-6.85%
Growth Streak

GL Income Statement

Compare GL to Peers and Sector

Metrics to compare
GL
Peers
Sector
Relationship
P/E Ratio
11.8x15.2x10.0x
PEG Ratio
0.580.400.03
Price/Book
2.3x2.0x1.0x
Price / LTM Sales
2.3x1.6x2.9x
Upside (Analyst Target)
4.3%14.2%13.5%
Fair Value Upside
Unlock17.3%2.2%Unlock

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.

Industry
Insurance
Sector
Financial
Employees
3695

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
36.61M47.15%6.74B
Other Institutional Investors
29.94M38.55%5.51B
Public Companies & Retail Investors
11.10M14.29%2.04B
Total
77.64M100.00%14.29B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.7.14%5,542,5311,020,325
Vanguard Capital Management, LLC6.63%5,149,992948,062

People Also Watch

123.54
PRU
+0.46%
274.48
JBHT
+2.84%
118.66
PAYX
+0.84%
96.15
MET
+0.45%

FAQ

What Is the Globe Life (GL) Stock Price Today?

The Globe Life stock price today is 183.90 USD.

What Stock Exchange Does Globe Life Trade On?

Globe Life is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Globe Life?

The stock symbol for Globe Life is "GL."

Does Globe Life Pay Dividends? What’s The Current Dividend Yield?

The Globe Life dividend yield is 0.72%.

What Is the Globe Life Market Cap?

As of today, Globe Life market cap is 14.31B USD.

What Is Globe Life's Earnings Per Share (TTM)?

The Globe Life EPS (TTM) is 15.08.

When Is the Next Globe Life Earnings Date?

Globe Life will release its next earnings report on Oct 28, 2026.

From a Technical Analysis Perspective, Is GL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Globe Life Stock Split?

Globe Life has split 6 times.

How Many Employees Does Globe Life Have?

Globe Life has 3695 employees.

What is the current trading status of Globe Life (GL)?

As of Aug 04, 2026, Globe Life (GL) is trading at a price of 183.90 USD, with a previous close of 184.09 USD. The stock has fluctuated within a day range of 181.00 USD to 184.36 USD, while its 52-week range spans from 127.85 USD to 191.55 USD.

What Is Globe Life (GL) Price Target According to Analysts?

The average 12-month price target for Globe Life is 193.91 USD, with a high estimate of 225 USD and a low estimate of 166 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +5.44% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.